Redefining the R1 resection in pancreatic cancer

被引:511
作者
Verbeke, C. S.
Leitch, D.
Menon, K. V.
McMahon, M. J.
Guillou, P. J.
Anthoney, A.
机构
[1] Univ Leeds, Dept Histopathol, Leeds, W Yorkshire, England
[2] Univ Leeds, Dept Surg, Leeds, W Yorkshire, England
[3] Univ Leeds, Dept Med Oncol, Leeds, W Yorkshire, England
[4] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England
关键词
D O I
10.1002/bjs.5397
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Resection margin (RM) status in pancreatic head adenocarcinoma is assessed histologically, but pathological examination is not standardized. The aim of this study was to assess the influence of standardized pathological examination on the reporting of RM status. Methods: A standardized protocol (SP) for pancreaticoduodenectomy specimen examination, involving multicolour margin staining, axial slicing and extensive tissue sampling, was developed. RI resection was defined as turnout within I turn of the RM. A prospective series reported according to this protocol (SP series, n = 54) was compared with a historical matched series in which a non-standardized protocol was used (NSP series, n = 48). Results: Implementation of the SP resulted in a higher RI rate overall, and for pancreatic (22 of 26 85 per cent) compared with ampullary (four of 15) and bile duct (six of 13) cancer. Sampling of the circumferential RM was more extensive in the SP series and correlated with RM status. RM involvement was often multifocal (14 of 32), affecting the posterior RM most frequently (21 of 32). Survival correlated with RM status for the entire SP series (P < 0.001), but not for the NSP series. There was a trend towards better median and actuarial 5-year survival after R0 resection in the SP pancreatic cancer subgroup. Conclusion: Standardized examination influences the reporting of RM status.
引用
收藏
页码:1232 / 1237
页数:6
相关论文
共 25 条
[1]  
Albores-Saavedra J, 1999, AM J CLIN PATHOL, V111, P304
[2]   Current standards of surgery for pancreatic cancer [J].
Alexakis, N ;
Halloran, C ;
Raraty, M ;
Ghaneh, P ;
Sutton, R ;
Neoptolemos, JP .
BRITISH JOURNAL OF SURGERY, 2004, 91 (11) :1410-1427
[3]  
ALLEMA JH, 1995, CANCER, V75, P2069, DOI 10.1002/1097-0142(19950415)75:8<2069::AID-CNCR2820750807>3.0.CO
[4]  
2-7
[5]  
Benassai G, 2000, J SURG ONCOL, V73, P212
[6]   Does anyone survive pancreatic ductal adenocarcinoma?: A nationwide study re-evaluating the data of the Finnish Cancer Registry [J].
Carpelan-Holmström, M ;
Nordling, S ;
Pukkala, E ;
Sankila, R ;
Lüttges, J ;
Klöppel, G ;
Haglund, C .
GUT, 2005, 54 (03) :385-387
[7]  
Chatelain D, 2002, ANN PATHOL, V22, P422
[8]   PROGNOSTIC INDICATORS FOR SURVIVAL AFTER RESECTION OF PANCREATIC ADENOCARCINOMA [J].
GEER, RJ ;
BRENNAN, MF .
AMERICAN JOURNAL OF SURGERY, 1993, 165 (01) :68-72
[9]   Favourable prognostic factors in a large UK experience of adenocarcinoma of the head of the pancreas and periampullary region [J].
Jarufe, NP ;
Coldham, C ;
Mayer, AD ;
Mirza, DF ;
Buckels, JAC ;
Bramhall, SR .
DIGESTIVE SURGERY, 2004, 21 (03) :202-209
[10]  
KAYAHARA M, 1993, CANCER, V72, P2118, DOI 10.1002/1097-0142(19931001)72:7<2118::AID-CNCR2820720710>3.0.CO